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Thiamine Acquisition Strategies Impact
Metabolism and Competition in the Gut
Microbe Bacteroides thetaiotaomicron
Zachary A. Costliow, Patrick H. Degnan
Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
ABSTRACT Thiamine (vitamin B1) is an essential cofactor for all organisms. Humans
primarily acquire thiamine through their diet, and thiamine deficiencies have ad-
verse neurological effects. However, the role gut microbes play in modulating thia-
mine availability is poorly understood, and little is known about how thiamine im-
pacts the stability of microbial gut communities. To investigate thiamine’s role in the
gut, we utilized the model gut microbe Bacteroides thetaiotaomicron. Transcriptome
sequencing (RNA-seq) revealed a global downregulation of thiamine and amino acid
biosynthesis, glycolysis, and purine metabolism when thiamine was present. Using
genetic mutants with thiamine biosynthesis and transport locus mutations, we de-
termined both systems were critical for growth in thiamine-deficient medium. The
defect in the double transport mutant suggests an uncharacterized feedback mecha-
nism between thiamine transport and biosynthesis in B. thetaiotaomicron. Mutant
phenotypes were recapitulated during pairwise competitions, reinforcing the impor-
tance of encoding versatile thiamine acquisition mechanisms when thiamine con-
centrations are variable. In addition, liquid chromatography-mass spectrometry (LC-
MS) analyses corroborate that exogenous thiamine levels affect the internal thiamine
pool of B. thetaiotaomicron. Furthermore, we computationally examined the ability
of other gut microbes to acquire thiamine and identified lineage-specific differences
in thiamine acquisition strategies. Among the Bacteroidetes, the capacities for both
thiamine transport and biosynthesis are common. Together, these data show that
thiamine acquisition mechanisms used by B. thetaiotaomicron not only are critical for
its physiology and fitness but also provide the opportunity to model how other gut
microbes may respond to the shifting availability of thiamine in the gut.
IMPORTANCE Variation in the ability of gut microbes to transport, synthesize,
and compete for vitamin B1 (thiamine) is expected to impact the structure and
stability of the microbiota, and ultimately this variation may have both direct
and indirect effects on human health. Our study identifies the diverse strategies
employed by gut Bacteroidetes to acquire thiamine. We demonstrate how the
presence or absence of thiamine biosynthesis or transport dramatically affects
the abundance of B. thetaiotaomicron in a competitive environment. This study
adds further evidence that altering the presence or concentrations of water-
soluble vitamins such as thiamine may be an effective method for manipulating
gut community composition. In turn, targeted thiamine delivery could be used
therapeutically to alter dysbiotic communities linked to disease.
KEYWORDS competition, microbiome, pnuT, thiamine pyrophosphate (TPP),
vitamin B1
Thiamine, a small metabolite vitamin is an essential cofactor in all three domains oflife. Thiamine is necessary for glycolysis, the tricarboxylic acid (TCA) cycle,
branched-chain amino acid metabolism, and nucleotide metabolism (1). Deficiencies of
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thiamine in humans can lead to neurodegenerative disorders, such as Wernicke’s
encephalopathy and beriberi, as well as heart failure, ataxia, and paralysis (2). In
humans, thiamine is believed to be primarily derived from dietary sources, such as
protein-rich foods as well as fortified grains (2), and is absorbed throughout the small
and large intestines (3). However, there is evidence that thiamine availability is mod-
ulated by or acquired from the dense and diverse microbial communities present in the
gastrointestinal tract (3–5).
Competition for and production of small metabolites such as vitamins, amino acids,
and short-chain fatty acids influence the composition (e.g., abundance and types) of
microbes that inhabit the gastrointestinal tract (6–8). As such, small metabolites are
therapeutic candidates for treatment of diseases associated with radical changes in gut
microbial community composition, such as Alzheimer’s, diabetes, and obesity (9–11).
Indirect evidence suggests thiamine may influence gut community structure. Metag-
enomic analysis of human cohorts of different ages determined that not only did
overall microbial communities change with age, but the abundance of microbial
thiamine biosynthesis genes increased with the age of the host (12). Conversely, in a
separate study the activity of human intestinal thiamine transporters was observed to
decrease with age (13). These observations may indicate a lower requirement for
thiamine by the host with age or possibly an increase in thiamine availability due to
microbial production in older individuals. While these correlative data exist, little is
known mechanistically about how the competition for and production of thiamine
impact individual gut microbes like Bacteroides thetaiotaomicron, microbial gastroin-
testinal communities, or human health.
Microbial thiamine biosynthesis is a bifurcated pathway involving the synthesis of
two precursors that are condensed to form thiamine (14). Microbes that lack complete
de novo biosynthesis of thiamine often encode partial biosynthetic pathways of the
precursors thiazole and hydroxymethyl pyrimidine phosphate or simply phosphorylate
free thiamine into the biologically active form, thiamine pyrophosphate (TPP) (15).
Organisms that lack or have incomplete biosynthetic pathways require transporters for
thiamine or its precursors. Humans exclusively transport free thiamine in the proximal
small intestine as well as in the large intestine (13), while some microbes like Salmonella
enterica use an ABC transporter to acquire thiamine and its phosphorylated forms (16).
However, despite our understanding of thiamine biosynthesis and metabolism in
humans and a limited number of model organisms, little is known about thiamine
acquisition strategies among most beneficial gut microbes.
Initial comparative genomic analyses of several gut microbes suggested that the
Bacteroidetes, a phylum that can comprise as much as 50% of the gastrointestinal
community (17), possess a canonical thiamine biosynthesis pathway (18). In addition, a
novel transport system was predicted due to the presence of cis-acting RNA regulatory
elements, TPP riboswitches, preceding putative transport genes (18). However, limited
investigation of thiamine acquisition in the Bacteroidetes has been attempted (19).
Here, we have carried out a bioinformatic analysis of 641 gut-associated microbes and
performed a transcriptomic, genetic, and competitive characterization of the prominent
gut microbe B. thetaiotaomicron in response to thiamine. In turn, we have characterized
(i) the effect of thiamine on the transcriptome, (ii) the predicted thiamine biosynthesis
and transport genes, (iii) the competitive defects of biosynthesis and transport mutants,
and (iv) the effects that exogenous thiamine has on the internal thiamine pool of
B. thetaiotaomicron.
RESULTS
Global gene expression response of B. thetaiotaomicron to thiamine avail-
ability. B. thetaiotaomicron, a prominent gut microbe, is typical of the Bacteroidetes in
its thiamine acquisition strategy, containing TPP riboswitch-regulated biosynthesis
(thiSEGCHF-tenI [BT0653 to BT0647]), putative outer membrane transporter (OMthi
[BT2390]), and putative inner membrane transporter, and thiamine pyrophosphorylase
(pnuT-tnr3 [BT2396 to BT2397]) operons (18). TPP riboswitches can act at the transcrip-
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tional or translational level (20), and it is uncertain how they function in the Bacte-
roidetes. To investigate the response of B. thetaiotaomicron to the availability of
thiamine, strand-specific transcriptome sequencing (RNA-seq) was performed on cul-
tures grown in minimal medium supplemented with either 0 or 15 M thiamine in
duplicate. A total of 34,890,999 reads were recovered, ranging from approximately 8
million to 9.5 million reads per sample that were quality filtered, trimmed, and analyzed
with Rockhopper (see Table S1 in the supplemental material) (21). Of the 4,778 coding
sequences in the B. thetaiotaomicron genome, 151 showed a 2-fold expression
change (false-discovery rate [FDR], q  0.05). Of the three putative TPP riboswitch-
regulated operons, the biosynthetic operon as a whole was significantly downregulated
when thiamine was present (Fig. 1A). No significant differential expression was ob-
served at either of the predicted transport operons (Fig. 1A). This is in striking contrast
to the multiple vitamin B12 riboswitch-regulated B12 transporters in B. thetaiotaomicron,
which exhibit a strong transcriptional induction when grown under vitamin B12-limiting
conditions (6). However, this does not rule out their involvement in thiamine transport,
particularly as the putative inner membrane transporter, PnuT, has been heterologously
expressed in Escherichia coli and demonstrated to transport thiamine (19).
In addition to the genes in the biosynthetic operon, 148 other genes were differ-
entially expressed due to exogenous thiamine in the environment. In fact, 132 of the
151 differentially regulated genes were downregulated when 15 M thiamine was
present in the medium (Fig. 1B). Using gene set enrichment analysis (GSEA), we
determined if specific pathways are differentially expressed due to thiamine availability
(22). Significantly downregulated KEGG pathways in the presence of exogenous thia-
mine were observed in thiamine metabolism, amino acid biosynthesis, purine meta-
bolism, the TCA cycle, coenzyme A biosynthesis, and pyruvate metabolism (FDR-
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FIG 1 Transcriptomic response of B. thetaiotaomicron to exogenous thiamine. (A) A schematic of TPP riboswitch-regulated operons is shown with expression
fold changes indicated and colored according to the heat map. Asterisks indicate individual genes that are significantly downregulated (q  0.05) in the
presence of thiamine. (B) Genome-wide expression response of B. thetaiotaomicron to thiamine. Gray circles indicate genes that are not significantly up- or
downregulated, red circles are genes significantly downregulated in the presence of thiamine, and green circles are genes significantly upregulated (q  0.05).
(C) KEGG gene clusters that contain genes which are significantly downregulated. The numbers to the right of each KEGG pathway denote the number of genes
downregulated in each category. Underlined categories indicate KEGG pathways that are significantly downregulated through GSEA analysis (P  0.05).
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corrected P  0.001) (Fig. 1C). This suggests that in the presence of excess exogenous
thiamine, B. thetaiotaomicron downregulates transcription of the thiamine biosynthetic
pathway in order to maintain homeostatic levels of internal thiamine. In addition to
this, B. thetaiotaomicron also decreases transcription of thiamine-dependent pathways
such as branched-chain amino acid biosynthesis, glycolysis, and the citric acid cycle
when excess thiamine is present. This decreased expression in the presence of excess
thiamine is counterintuitive to what was expected. Normally, it is expected that
expression of cofactor-dependent enzymes is positively correlated with the concentra-
tion of the cofactor (e.g., iron) (23). In the case of thiamine in B. thetaiotaomicron, we
observe the opposite. The expression of thiamine-dependent enzymes was inversely
correlated.
Genetic analysis of thiamine acquisition genes in B. thetaiotaomicron. To assess
the conditions under which thiamine biosynthesis and uptake are important for the
growth of B. thetaiotaomicron and validate the role of the predicted transporters in
thiamine uptake, a series of in-frame genetic deletions were generated. We focused on
the three TPP riboswitch-regulated operons, removing the entirety of the downstream
biosynthetic or putative transport coding sequences. The resulting mutant strains and
their complements (Table 1) were evaluated for their ability to grow under a range of
exogenous thiamine concentrations.
Wild-type B. thetaiotaomicron readily grows in media without added thiamine
(Fig. 2A) (24), which corresponds with elevated expression of the TPP riboswitch-
regulated thiSEGCHF-tenI operon identified by RNA-seq. Therefore, deletion of the
major thiamine biosynthetic operon (ΔBioThi [BT0653 to BT0647]) is expected to
completely inhibit growth in minimal medium without thiamine. Indeed, growth
inhibition occurs in the ΔBioThi mutant, severely attenuating terminal cell densities
(Fig. 2A and B). Partial growth of the ΔBioThi mutant is recovered when the medium is
supplemented with 1 nM thiamine (Fig. 2B). The calculated 50% effective concentra-
tion (EC50: the effective concentration of thiamine at which the terminal optical density
at 600 nm [OD600] of the mutant attains 50% of the wild-type level) (see Table S2 in the
supplemental material) for the ΔBioThi mutant is 2.8 nM (95% confidence interval [CI],
1.4 to 5.5 nM), showing that biosynthesis is critical in thiamine-deficient environments.
This growth defect can be complemented when the thiSEGCHF-tenI operon and its
native promoter are returned to the ΔBioThi mutant in trans (Fig. 2B), alleviating the
requirement for exogenous thiamine and returning the EC50 to 0 nM thiamine (Ta-
ble S2). Together these data suggest that B. thetaiotaomicron does in fact encode
thiamine transporters that likely function in the low-nanomolar range. This is compa-
TABLE 1 Deletion loci and complements generated in this study
Strain type Description
WT Wild-type deletion background, ΔBT2275 FUdRr, intact thiamine biosynthetic and transport operonsa
Deletion mutants
ΔBioThi Deletion of thiamine biosynthetic operon thiSEGCHF-tenI (BT0647–BT0653 [797661–803616])
ΔOMthi Deletion of putative outer membrane, TonB-dependent thiamine transporter BT2390 (2977834–2980058)
ΔpnuT Deletion of putative inner membrane thiamine transporter BT2396 (2992218–2992778)
ΔΔBioThi-OMthi Deletion of BT0647–BT0653 and BT2390
ΔΔBioThi-pnuT Deletion of BT0647–BT0653 and BT2396
ΔΔTransport Deletion of BT2390 and BT2396
ΔΔΔ Deletion of BT0647–BT0653, BT2390, and BT2396
Complementation constructs
ΔBioThipBioThi BT0647–BT0653 complemented in trans
ΔΔBioThi-OMthipBioThi BT0647–BT0653 complemented in trans
ΔΔBioThi-pnuTpBioThi BT0647–BT0653 complemented in trans
ΔΔTransportpOMthi BT2390 complemented in trans
ΔΔTransportppnuT BT2396 complemented in trans
ΔΔTransportppnuTOMthi BT2396 and BT2390 complemented in trans
aFor details, see reference 33.
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rable to other characterized thiamine transporters such as ThiPQ-TbpA in Salmonella
enterica serovar Typhimurium (16).
To determine if the predicted TPP riboswitch-regulated inner (pnuT [BT2396]) and
outer (OMthi [BT2390]) membrane transporters are responsible for transporting thia-
mine, individual transporter deletions were constructed in the wild-type background
(ΔpnuT and ΔOMthi). Regardless of the thiamine concentration in the medium, growth
of the single transporter mutants never significantly varied from wild type (Fig. 2B). This
result was expected as the thiamine biosynthesis pathway is fully intact. Therefore, to
further investigate the role of these transporters, double mutants consisting of either
the biosynthetic operon and a single transporter or both transporters were generated.
Deletion of the biosynthetic operon in conjunction with either the inner membrane
(ΔΔBioThi-pnuT) or outer membrane (ΔΔBioThi-OMthi) transporters resulted in mutants
that required ~10 times more thiamine (1,000 nM) than the ΔBioThi mutant to achieve
growth equal to that of the wild type (Fig. 2C). The EC50 for the double mutants
increased to 15.8 nM (95% CI, 8.1 to 31 nM) thiamine for the biosynthesis and outer
membrane transporter mutant and to 10.9 nM (95% CI, 9.2 to 13 nM) for the biosyn-
thesis and inner membrane transporter double mutant compared to an EC50 of 2.8 nM
(95% CI, 1.4 to 5.5 nM) in the biosynthesis mutant (Table S2). Thus, partial disruption of
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FIG 2 Growth phenotypes of B. thetaiotaomicron thiamine acquisition mutants. Thiamine acquisition operons have differential effects on
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Thiamine Acquisition Strategies of B. thetaiotaomicron
September/October 2017 Volume 2 Issue 5 e00116-17 msystems.asm.org 5
thiamine transport in the absence of a complete biosynthetic pathway further atten-
uates but does not completely abolish thiamine-dependent growth. Growth of either of
these two mutant backgrounds can be fully complemented by restoring the major
thiamine biosynthesis operon in trans (Fig. 2C).
Compared to the individual biosynthesis and transporter mutants, deletion of both
transporters while the biosynthesis locus is fully intact (ΔΔTransport) has a highly
deleterious effect on growth (Fig. 2D). This mutant requires at least 10 M thiamine to
achieve wild-type growth and has an EC50 of 30.3 nM (95% CI, 22.8 to 40.3 nM)
(Table S2). To ensure this phenotype was not due to an inability to transport cysteine,
the only thiamine precursor present in the minimal medium, the double transport
mutant was grown with an alternate sulfur source. The growth phenotype of the
mutant in the modified medium was unchanged, suggesting that neither transporter is
likely involved in cysteine transport (see Text S1 and Fig. S1 in the supplemental
material).
Individual complementation constructs were generated for the inner and outer
membrane components and introduced in trans into the double transport mutant
(ΔΔTransportppnuT and ΔΔTransportpOMthi). Although we did not observe full
complementation by either of the two constructs, they did significantly improve the
EC50 from 30.3 nM (95% CI, 22.8 to 40.3 nM) in the double transport mutant to 1.9 nM
(95% CI, 0.8 to 4.4 nM) and 0.1 nM (95% CI, 0 to 1.9 nM) (Table S2) in the outer and inner
membrane transport complements, respectively (t test, P 0.0001) (Fig. 2D). In addition
to single transport complements, a double transport complement (ΔΔTransportppnuT
OMthi) was made and tested with similar results to the single transport complements.
The double complement allowed for better fitness at low levels of thiamine, achieving
35% of wild-type growth at 0 nM added thiamine and greater than 80% of wild-type
growth at 10 nM (see Fig. S2 in the supplemental material). It also significantly
improved the ΔΔTransport mutant’s EC50 from 30.3 nM to 0.1 nM (95% CI, 0 to 0.2 nM)
(Table S2). While not uncommon, it is possible that with introduction of the comple-
mentation vectors in trans, the complements were not expressed at the same level as
the wild type or are missing key upstream elements preventing the strains from
growing as well as wild-type B. thetaiotaomicron (Fig. 2D).
A final triple mutant of all three TPP-regulated loci was generated (ΔΔΔ). This strain
demonstrated a similar level of growth inhibition to the double transport mutant
(Fig. 2D). It required 10 M thiamine in the medium to attain 100% wild-type growth
(EC50 of 51.9 nM; 95% CI, 42.4 to 63.6 nM) (Table S2). It is important to note that growth
defects only affected the terminal density of the mutants, and the doubling times
remained fairly constant (~2 h). Together these data confirm the crucial role these
operons play in producing and acquiring thiamine.
Factors affecting the phenotype of the double transport mutant. To determine
if dysregulation of biosynthesis played a role in the severe growth phenotype of the
double transport mutant, reverse transcription-quantitative PCR (RT-qPCR) was per-
formed. Consistent with the RNA-seq data (Fig. 1), expression of the major biosynthetic
operon in wild-type B. thetaiotaomicron is upregulated under thiamine-deficient con-
ditions (0 and 100 nM) compared to under the replete condition (10,000 nM) (Fig. 3A
and B). In a thiamine-deficient environment, gene thiC (Fig. 3A) is expressed 9.2-fold
higher in 0 nM thiamine than in 10,000 nM and 3.3-fold higher than in 100 nM thiamine
(Fig. 3A). Similarly the expression of thiS is expressed 2.7-fold to 2-fold higher in 0 nM
thiamine than in 10,000 and 100 nM, respectively (Fig. 3B). As noted above the
ΔΔTransport mutant cannot be cultured in 0 nM thiamine, but thiC and thiS expression
was determined in 100 and 10,000 nM thiamine. In marked contrast with the wild type,
expression of thiC and thiS is repressed over 100-fold in media with 100 or 10,000 nM
thiamine. These data suggest that transport and biosynthesis are linked and likely
contribute to the severe growth defect in the ΔΔTransport mutant despite the presence
of an intact biosynthetic operon.
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In addition, we also performed RT-PCR on tnr3, which occurs immediately down-
stream of pnuT, to ensure that the generation of the ΔΔTransport mutant did not have
a polar effect (Fig. 3C). The expression of tnr3 remains unchanged in wild-type and the
ΔΔTransport mutant cells regardless of the thiamine concentration tested. Given this
result, we infer that the fitness defect is not due to a polar effect of deleting the
transport genes.
Consequences of thiamine acquisition on competition. We investigated the
competitive capacities of the B. thetaiotaomicron thiamine acquisition mutants in
pairwise competitions with wild-type B. thetaiotaomicron. To determine if coculture
increased (competition) or decreased (cross-feeding) the individual phenotypes, mixed
cultures were serially passaged for 5 days in media with 0, 10, 100, 10,000 nM
exogenous thiamine, and strain abundances were monitored through time by qPCR
(Fig. 4; see Fig. S3 in the supplemental material). The single transport mutants (ΔpnuT
and ΔOMthi) successfully coexisted with wild-type B. thetaiotaomicron under every
condition tested (Fig. 4A and B). The mutants maintained 60 to 80% of the population
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throughout the 5 days of serial passaging. Although the abundance of the mutants
fluctuated during passaging, this was likely due to stochastic effects during the daily
inoculations (Fig. S3). Together, these results extend the individual growth findings and
show that cells lacking either the inner or outer membrane transporters are not at a
disadvantage when grown in competition with the wild-type strain that encodes both
fully intact transporters.
In contrast, the ΔBioThi mutant was rapidly outcompeted in the absence of thia-
mine, falling to 0.1% of the population by day 5, despite initially making up 90% of
the population. As exogenous thiamine levels were increased, the fitness defect was
alleviated. At 10 nM thiamine, the wild type dominated the competition; by day 5,
however, the ΔBioThi mutant only dropped to 44% of the population. As the concen-
trations of thiamine increased to 100 and 10,000 nM, the ΔBioThi mutant showed no
fitness defect, maintaining 80% of the population throughout the competition
(Fig. 4C). Similarly, the ΔΔBioThi-pnuT and ΔΔBioThi-OMthi strains are dramatically
outcompeted in 0 and 10 nM added thiamine to the level that they are not even
detectable. As thiamine is increased in concentration, the abundance of the double
biosynthesis and transporter mutants stabilizes at ~55% of the population for the
ΔΔBioThi-OMthi mutant and ~66% of the population for the ΔΔBioThi-pnuT mutant,
respectively (Fig. 4D and E). The ΔΔTransport and ΔΔΔ mutants were also interrogated
for their competitive abilities. We observed severe phenotypes with both mutants in 0,
10, and 100 nM thiamine (Fig. 4F and G). The mutants were rapidly outcompeted by the
wild type within the first 3 days and driven below the level of detection by day 5
(Fig. S3). Only in 10,000 nM did the ΔΔTransport mutant and the ΔΔΔ mutant coexist
with the wild type—maintaining 40% and 80%, respectively, at day 5. These results
essentially mirror the individual growth data for the mutants and suggest that wild-
type B. thetaiotaomicron does not cooperate with or facilitate the growth of these
mutants, indicating that B. thetaiotaomicron does not appear to release thiamine to the
environment under in vitro growth conditions.
Quantification of cell-associated thiamine. Intracellular concentrations of thia-
mine, thiamine monophosphate (TMP), and TPP were measured after wild-type
B. thetaiotaomicron cultures were grown in four different concentrations of thiamine (0,
10, 100, and 10,000 nM). In all the B. thetaiotaomicron cultures tested, the cofactor form
TPP is the predominant moiety, averaging between 100,000 and 250,000 molecules per
cell (Fig. 5A) and constituting 70 to 87% of the total thiamine (Fig. 5B). Therefore,
despite a 10,000 increase in the amount of exogenous thiamine, the internal con-
centration changes no more than 2.5-fold. As such, thiamine moieties appear to be
maintained within some homeostatic range. However, as exogenous thiamine levels
increase, we did detect marginally significant increases in thiamine and TMP concen-
trations (Fig. 5A). While TMP maintains 9 to 14% of the thiamine pool in spite of its
increased concentrations, thiamine itself increases from ~2 to 16% of the total pool
(Fig. 5B). These data suggest thiamine may be entering the cell via nonspecific
mechanisms—the same mechanisms responsible for the ability of the ΔΔTransport and
ΔΔΔ mutants to grow in 10,000 nM thiamine. As a result, this excess thiamine may
impede or exceed the capacity of the thiamine pyrophosphorylase, Tnr3.
Identification of thiamine acquisition genes in gut Bacteroidetes. To expand
upon the knowledge gained from our experiments in B. thetaiotaomicron, we interro-
gated 641 genomes from 5 phyla and 11 classes of gut bacteria for the presence of
thiamine-dependent enzymes. Every one of the 641 genomes encoded at least one
thiamine-dependent enzyme (Fig. 6A). We then determined the route by which these
bacteria acquire thiamine by examining their genome’s ability to synthesize, transport,
FIG 4 Legend (Continued)
and (F) ΔΔΔ thiamine acquisition mutants were performed over 4 or 5 days in defined thiamine concentrations. Strain
abundances were quantified by qPCR and are represented as a percentage of the entire community at 4 concentrations
of thiamine (0, 10, 100, and 10,000 nM). Error bars represent the standard error of the mean from three biological
replicates.
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or recycle thiamine. Only 48% (307/641) of the genomes investigated have readily
identifiable, complete thiamine biosynthesis pathways, implying that many gut mi-
crobes likely compete with one another and/or the host for this essential cofactor
(Fig. 6A).
All of the gut Bacteroidetes genomes examined exhibit evidence of requiring thia-
mine (n  114). This includes encoding one or more putatively thiamine-dependent
enzymes (mean SD, 13 2 genes) or a thiamine-binding riboswitch (mean SD, 2
1 genes). As such, thiamine biosynthesis and transport genes occur in 94% (107/114) of
gut-associated Bacteroidetes (Fig. 6B). A minority of sequenced Bacteroidetes from the
gut encode biosynthesis (n  2) or transport (n  5) alone.
Thiamine biosynthesis occurs in one of two configurations in gut-associated Bacte-
roidetes. The majority of genomes, including B. thetaiotaomicron, have a pathway in
which 4-amino-2-methyl-5-diphosphomethylpyrimidine (HMP-PP) is synthesized by
ThiC and ThiD (blue in Fig. 6B and C) and 2-(2-carboxy-4-methylthiazol-5-yl)ethyl
phosphate (cTHz-P) is produced by ThiSFGH-TenI (orange in Fig. 6B and C) (14). These
precursors are condensed into thiamine monophosphate by ThiE or YjbQ (tan in Fig. 6B
and C), which is then phosphorylated into the biologically active form of thiamine
pyrophosphate by ThiL (green in Fig. 6B and C). A handful of gut-associated Bacte-
roidetes have replaced the canonical cTHz-P biosynthetic branch with a THI4-like
thiazole synthase enzyme (13/109; EC 2.8.1.10) (fuchsia in Fig. 6B and C). Regardless, all
109 genomes encoding a major biosynthetic operon also encode a TPP riboswitch
immediately upstream (18).
None of the gut-associated Bacteroidetes possesses a recognizable thiamine ABC
transport system similar to the characterized ThiQP-TbpA of Gram-negative bacteria or
YkoEDC of Gram-positive bacteria (16, 18). Moreover, Bacteroidetes lack the ThiT thia-
mine transporter and the CytX and ThiW precursor transport proteins (18). Thus, like
B. thetaiotaomicron, the previously uncharacterized inner and outer membrane trans-
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FIG 5 Quantification of thiamine pools in B. thetaiotaomicron. (A) Intracellular quantification of thiamine
and its phosphorylated moieties indicates that total quantities of thiamine, TMP, and TPP increase to
various degrees as exogenous thiamine is increased. The values shown represent the average and
standard error of the mean from six biological replicates. Letters for individual moieties indicate groups
that are not significantly different from each other (P 0.05, Tukey’s honestly significant difference [HSD]
test). (B) The proportions of thiamine and TMP increase as the concentration of exogenous thiamine
increases, while the proportion of TPP decreases.
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porters (PnuT and OMthi) are widely conserved in gut Bacteroidetes, with more than
three-quarters (91/114) of the genomes analyzed carrying both OMthi and pnuT
(Fig. 6B). However, heterogeneity in the presence and genomic organization of these
genes exists. While B. thetaiotaomicron carries a split operon, most genomes contain
OMthi, pnuT, and tnr3 as a single operon, and others have apparently lost some or all
of these genes (e.g., Bacteroides coprocola). In most instances, the TPP riboswitch is
retained and sometimes duplicated when the operon is split.
DISCUSSION
Thiamine is an essential cofactor for all living organisms: as such, its availability
impacts human health as well as that of our microbiota. Here, we have identified
substantial genetic diversity within and among gut bacterial phyla for acquiring
thiamine, suggesting diverse strategies are employed leading to opportunities for
cooperation and/or competition (Fig. 6A). Among the Bacteroidetes, a ubiquitous and
abundant gut phylum responsible for carbohydrate fermentation, fatty acid production,
and immune function (25, 26), we identified three distinct strategies for thiamine
acquisition: biosynthesis and transport, biosynthesis alone, and transport alone. We
analyzed the expression profiles, dissected the genetics, and examined the competitive
advantages of these strategies in B. thetaiotaomicron, demonstrating the importance of
both thiamine biosynthesis and transport.
Our results demonstrate that the biosynthesis of thiamine is essential for growth
and competition of B. thetaiotaomicron in environments with limited thiamine avail-
ability. Like many Bacteroidetes, B. thetaiotaomicron carries a major biosynthetic gene
operon (BioThi [BT0653 to BT0647]), which includes essential enzymes for both HMP-PP
and cTHz-P production and condensation (Fig. 1A and 6B). Our genome-wide expres-
sion profiling identified evidence of thiamine-dependent regulation of this locus that
we attribute to the TPP-binding riboswitch preceding this operon. This expression
response is consistent with reanalysis of microarray data from B. thetaiotaomicron
grown both in vitro and in vivo under thiamine-variable conditions (see Fig. S4 in the
supplemental material) (27). Subsequent deletion of the entire biosynthetic operon in
B. thetaiotaomicron renders it auxotrophic for thiamine, severely impairing growth in
media with less than 10 nM thiamine. Both the genetic organization of the locus and
a similar growth defect of a thiC deletion mutant are seen in S. enterica (28). Moreover,
the defect in B. thetaiotaomicron, which can be complemented by restoring the entire
biosynthetic operon in trans, is recapitulated during coculture with wild-type cells.
Competitions result in the ΔBioThi mutant being outcompeted by the wild-type cells
during a multiday coculture experiment under low- or no-thiamine concentrations. We
note that thiamine availability in the gut is expected to fluctuate due to various factors,
including host genetics, diet, and intestinal adsorption. Measurements of thiamine in
the intestinal lumen range between 20 and 2,000 nM (13). As such, a gut microbe’s
ability to synthesize its own thiamine is likely most important during transient drops in
thiamine availability to enable the microbe’s own growth. We predict that gut microbes
that we have identified that are wholly dependent on thiamine transport, such as
members of the genus Alistipes and many members of the bacilli (Fig. 6), to be
adversely affected during such drops in thiamine availability.
FIG 6 Legend (Continued)
that encode a thiamine-dependent enzyme and predicted thiamine acquisition strategies. Values in
parentheses represent the number of genome sequences in each class. (B) The presence and absence of
predicted thiamine biosynthesis and transport genes in diverse gut Bacteroidetes are indicated. The
phylogeny represents a maximum likelihood reconstruction of gut Bacteroidetes species. Numbers in
parentheses represent the number of individual strains analyzed, and nodes marked with black circles
indicate bootstrap values of 75. The asterisk indicates that one of the five B. uniformis genomes
analyzed is missing pnuT and tnr3, but this may be an assembly artifact. (C) Schematic representation of
thiamine biosynthesis in the Bacteroidetes. Arrow colors correspond to the key in panel B. Gene names
in gray are missing, and names in green are genes that are not solely dedicated to the biosynthesis of
thiamine.
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Our global transcriptomic analysis revealed differential responses of thiamine ac-
quisition operons to exogenous thiamine. Under conditions of excess thiamine, we
have shown that B. thetaiotaomicron downregulates the BioThi operon. However, we
found that transcripts for the putative inner (pnuT) and outer (OMthi) membrane
transporter genes adjacent to TPP-binding riboswitches show minimal expression
differences (Fig. 1A). These proteins were previously predicted to function in thiamine
transport (18), and PnuT was recently shown to transport thiamine in a heterologous
host (19). Curiously, individual deletions of these transporters have no effect on the
growth of mutants individually or in coculture with wild-type cells. However, deletion
of both transport genes in tandem yielded a severe growth defect (Fig. 2). After ruling
out an additional role of these transporters for importing a critical precursor (Fig. S1),
we speculate that they may play a role in thiamine recycling or that there is an
uncharacterized connection between biosynthesis and transport of thiamine. When we
measured expression of the BioThi operon in the double transport mutant using
RT-qPCR we found expression of thiC and thiS was downregulated (Fig. 3A and B). This
raises the possibility that an unknown protein regulatory mechanism may be dysregu-
lated and repressing biosynthesis in the ΔΔTransport mutant. Regardless, further
investigations are warranted to disentangle thiamine biosynthesis and transport and
their interconnected pathways.
The dual transport and biosynthesis pathways appear to facilitate the ability of
wild-type B. thetaiotaomicron to maintain a fairly stable intracellular concentration of
the cofactor TPP (3-fold), despite radical changes in extracellular thiamine concen-
trations. However, these increases in intracellular concentrations of the thiamine moi-
eties are sufficient to lead to the downregulation of the BioThi operon in addition to a
suite of thiamine-dependent pathways, including amino acid metabolism and nucleo-
tide biosynthesis. It is possible that the increased proportion of thiamine to TPP may
provide a signal sensed by unknown regulatory mechanisms, outside the regulatory
riboswitches that control biosynthesis and transport genes. These additional regulatory
factors are likely important for modulating responses to the stress of variable levels of
exogenous thiamine.
We observed that competitions between B. thetaiotaomicron and thiamine acquisi-
tion mutants yielded similar results to growth of the mutants in isolation (Fig. 2 and 4),
suggesting that B. thetaiotaomicron does not release thiamine into the environment.
Confirming this hypothesis, no thiamine was detected in the supernatant of spent
cultures of B. thetaiotaomicron grown in thiamine-free medium (data not shown). This
is not in line with previously published data in which thiamine was still detectable in
the feces of a select group of humans who were completely thiamine starved (4). It was
inferred that the thiamine detectable in these patients was derived from their microbial
communities (4). This leads us to speculate that other gut microbes, including divergent
Bacteroidetes or Proteobacteria, release thiamine as they are the most prevalent thia-
mine synthesizers. Alternatively, host-driven cell lysis (29), microbe-microbe antago-
nism and/or intoxication (30), or some gut-specific signal results in the liberation of this
essential cofactor.
As an essential small molecule, thiamine appears to have an important role in the
persistence of microbes in the gut. The universal requirement for this cofactor and the
diverse strategies for acquisition result in scenarios that would force competition or
cooperation among gut microbes. Among B. thetaiotaomicron mutants encoding a
single acquisition strategy, we have observed competitive defects, similar to what has
been seen for B12 transport (6). However, more complex communities may be crucial to
enabling cooperation; thus, modeling the dynamics of thiamine in natural or recon-
structed gut communities will be a way forward to understand these dynamics. It thus
remains possible that cofactors such as thiamine may be utilized to manipulate gut
communities. Ultimately such manipulation may play a role in the combating of
diseases such as diabetes, obesity, and cancer.
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MATERIALS AND METHODS
Bacterial culturing and genetic manipulation. Routine culturing of B. thetaiotaomicron VPI-5482
occurred anaerobically at 37°C in liquid tryptone-yeast extract-glucose (TYG) medium (24) or Difco brain
heart infusion (BHI) agar with the addition of 10% defibrinated horse blood (Quad Five, Ryegate, MT).
Cultures were grown anaerobically within a vinyl anaerobic chamber with an input gas mixture
consisting of 70% nitrogen, 20% carbon dioxide, and 10% hydrogen (Coy Laboratory Products, Grass
Lake, MI). Escherichia coli S17-1  pir strains used for cloning and conjugation of suicide vectors were
grown in LB medium at 37°C aerobically. Antibiotics were added to the medium when appropriate in the
following concentrations: ampicillin, 100 g/ml; gentamicin, 200 g/ml; erythromycin, 25 g/ml; tetra-
cycline, 2 g/ml; and 5-fluoro-2=-deoxyuridine (FUdR), 200 g/ml.
Markerless deletions were generated via allelic exchange and confirmed by PCR (6, 31). Briefly, HiFi
Taq MasterMix (Kapa Biosystems, Wilmington, MA) was used to amplify the right and left flanks of
thiamine-associated loci by PCR, which were then combined by splicing by overlap extension (SOE) PCR.
Purified SOE products were restriction digested and cloned into pExchange_tdk vector by standard
methods (32). Sequence-confirmed vectors were then conjugated from donor E. coli S17-1  pir strains
into recipient B. thetaiotaomicron strains. Transconjugants were colony purified and screened for
successful mutants by PCR (Table 1). Complementation and bar-coded vectors were all constructed in
pNBU2 vectors and were introduced into the genome in a single copy (6, 33). Construction and
conjugation of pNBU2 vectors was done by the same methods as pExchange_tdk vectors. A complete list
of primers and vectors used for this study is provided in Table S3 in the supplemental material.
Thiamine transcriptomic response. A modified minimal medium was used for all thiamine growth
assays (after Varel and Bryant [34] and Scholle et al. [35]). The modified minimal medium consisted of
glucose (27.8 mM), ammonium chloride (6.0 mM), L-cysteine freebase (4.1 mM), sodium carbonate
(3.8 mM), iron sulfate (0.3 mM), vitamin B12 (5.8 M), a histidine-hematin solution (0.1% 1.9 mM hematin
in 0.2 M histidine), 1 M potassium phosphate buffer at a pH of 7.2 (2%), and a premixed mineral solution
(5%). The mineral solution consisted of 3 M sodium chloride, 3.6 mM calcium chloride dehydrate, 1.6 mM
magnesium sulfate, 1 mM manganese chloride tetrahydrate, and 84.1 M cobalt chloride hexahydrate.
Replicate cultures of wild-type B. thetaiotaomicron were grown overnight in 5 ml minimal medium
supplemented with 10,000 nM thiamine HCl (THI; 99% pure) (Sigma-Aldrich, St. Louis, MO). Aliquots of
each culture were pelleted by centrifugation (1 min at 13,300  g), culture supernatants were decanted,
and the cells were washed 4 times in minimal medium with 0 nM thiamine. Cells were inoculated into
10 ml of minimal medium with either 0 or 15 M thiamine HCl at a final dilution of 1:2,000 in biological
duplicate. Cell growth was monitored, and cells were harvested between an OD600 of 0.4 and 0.6 on a
UV spectrometer. Total RNA was extracted using the Qiagen RNeasy kit and stored at 	80°C. Total RNA
was DNase treated with DNase I (Thermo Fisher, Waltham, MA) and the NEB DNase treatment protocol.
DNase-treated RNAs were recleaned using the Qiagen RNeasy kit (Hilden, Germany), quantitated using
a Qubit 2.0 (Life Technologies, Inc., Carlsbad, CA), and stored at 	80°C.
RNA was submitted for integrity analysis, rRNA depletion, and library construction at the W. M. Keck
Center for Comparative and Functional Genomics at the University of Illinois at Urbana-Champaign.
For targeted gene expression analysis, total RNA was purified as described above and used to
generate cDNA libraries using a first-strand cDNA synthesis kit (Thermo Fisher, Waltham, MA). RT-qPCR
was performed on a Bio-Rad CFX Connect instrument (Bio-Rad, Hercules, CA) and SYBR Fast MasterMix
2 Universal (Kapa Biosystems, Wilmington, MA) following the manufacturer’s instructions for triplicate
biological samples in technical triplicates. Four genes were amplified: the 16S rRNA, thiC, thiS, and tnr3
genes. 16S rRNA primers were used as the control gene (6), and novel primers for thiC, thiS, and tnr3 were
designed using Primer3 (36). Standard curves were used to evaluate the efficiency of the amplification:
all 4 genes had R2 values of0.985 and slopes of between	3.33 and	3.40. Relative expression changes
were calculated by the quantification cycle (ΔΔCq) method (37).
RNA sequencing analysis. RNA-seq reads from each sample were quality filtered using a custom R
script and fastx_clipper (http://hannonlab.cshl.edu/fastx_toolkit/index.html). Filtered RNA-seq data were
analyzed using the Rockhopper program (21) to identify differentially expressed genes between
thiamine-replete and thiamine-deficient samples. Reads were aligned to the B. thetaiotaomicron VPI-5482
genome, and significantly differentially expressed genes were identified (2-fold change and q  0.05).
Assaying thiamine-dependent growth phenotypes. B. thetaiotaomicron wild-type, mutant, and
complemented strains were grown and washed in minimal medium with 0 M thiamine as described
above for RNA-seq. Cells were normalized, diluted to an OD600 of 0.0004, and dispensed into 96-well
plates with thiamine HCl, thiamine monophosphate HCl (TMP;95% pure) (Sigma-Aldrich, St. Louis, MO),
and thiamine pyrophosphate chloride (TPP; 98%) (Thermo Fisher Scientific, Waltham, MA) at concen-
trations ranging from 0 to 10,000 nM (modified from Degnan et al. [6]). Cell growth was measured over
the course of 25 h using a BioTek Synergy HTX Multi-Mode microplate reader in conjunction with a
BioStack3 microplate stacker (BioTek, Winooski, VT). All phenotypic assays were averaged from three to
nine biological replicates with three technical replicates each. All phenotypes were calculated as a
percentage of WT growth achieved in minimal medium plus 10,000 nM THI at 17.5 h. Pairwise Student’s
t tests were carried out using GraphPad Prism v6, and P values of 0.05 were considered significant.
In vitro competition assays. Cells were grown for 16 h in minimal medium supplemented with
10,000 nM thiamine HCl. Cells were pelleted and washed 4 times with minimal medium. Cell OD600 values
were normalized to 0.01. Cells were inoculated 1:100 into an Axygen deep-well plate (Corning, Inc.,
Corning, NY) in biological triplicate for each mutant at 4 different concentrations (0, 10, 100, and
10,000 nM) of thiamine HCl in minimal medium. Cultures were incubated anaerobically at 37°C for 24 h
and passaged 1:1,000 into the same medium type they were previously grown in (6, 33). Time points
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were taken for 4 to 5 days, and samples were saved in medium plus 20% glycerol at	80°C. Samples were
prepped for genomic DNA (gDNA) using the HotShot method (38), and the relative abundance of each
bar-coded strain was determined using qPCR in reference to a standard curve on a Bio-Rad CFX Connect
instrument (Bio-Rad, Hercules, CA) and SYBR Fast MasterMix 2 Universal (Kapa Biosystems, Wilmington,
MA) (6). Data were analyzed by the efficiency-corrected ΔCq method (37).
Quantification of thiamine in B. thetaiotaomicron and medium. B. thetaiotaomicron was grown in
either 0, 10, 100, or 10,000 nM thiamine HCl to the mid-log phase (OD600 of ~0.5). Cells were pelleted at
10,000  g for 2 min. Cells were washed three times with phosphate-buffered saline (PBS). Cells and
medium aliquots were submitted to the Roy J. Carver Biotechnology Centre’s Metabolomics Center at the
University of Illinois at Urbana-Champaign for quantification of thiamine, thiamine monophosphate, and
thiamine diphosphate. Samples were analyzed with the 5500 QTRAP liquid chromatography-tandem
mass spectrometry (LC-MS/MS) system (Sciex, Framingham, MA). Software Analyst 1.6.2 was used for data
acquisition and analysis. The 1200 series high-performance liquid chromatography (HPLC) system
(Agilent Technologies, Santa Clara, CA) includes a degasser, an autosampler, and a binary pump. The LC
separation was performed on a Phenomenex Polar column (4.6 by 100 mm, 4 m) with mobile phase A
(0.1% formic acid in water) and mobile phase B (0.1% formic acid in acetonitrile). The flow rate was
0.4 ml/min. The linear gradient was 0 to 3 min at 95% A, 6 to 9 min at 0% A, and 10 to 15 min at 95%
A. The autosampler was set at 10°C. The injection volume was 100 l. Mass spectra were acquired under
positive electrospray ionization (ESI) with an ion spray voltage of 5,000 V. The source temperature was
450°C. The curtain gas, ion source gas 1, and ion source gas 2 were 33, 50, and 65, respectively. Multiple
reaction monitoring (MRM) was used for quantitation: thiamine, m/z 265.0 and 122.0; thiamine mono-
phosphate, m/z 345.1 and 122.0, and thiamine diphosphate, m/z 425.1 and 122.0.
Computational prediction of thiamine-associated genes. Thiamine biosynthesis and transport
genes and thiamine-dependent genes were identified searching for gene-specific TIGRFAM (39) when
available or PFAM (40) hidden Markov models with HMMR (--tc_cut) (see Table S4 in the supplemental
material) in 641 gut bacteria, including 114 Bacteroidetes genomes available in RefSeq from the Human
Microbiome Project (see Table S5 in the supplemental material) (41, 42). Predicted annotations were
confirmed with BLAST and PFAM hidden Markov models (40, 43). Homologs of B. thetaiotaomicron
VPI-5482 loci were confirmed and compared among the other 113 Bacteroidetes genomes using a
reciprocal best BLAST approach. In addition, Infernal 2.0 was used to detect putative TPP riboswitches
adjacent to thiamine-associated genes (RF00059) (44, 45). The presence or absence of biosynthetic and
transporter genes was used to categorize the route of thiamine acquisition. Microbes capable of
complete “biosynthesis” have the ability to synthesize both HMP-PP (thiC or thi5 and thiD) and cTHz-P
(thiGH or thi4 in addition to tenI) and possess thiamine condensation genes (thiE and/or yjbQ) and a
thiamine kinase. Microbes categorized as capable of “recycling” lack the ability to completely synthesize
either thiazole and/or HMP-PP de novo but retain the thiamine kinase enzymes. Microbes were catego-
rized as capable of “transport” if any gene predicted to transport thiamine was identified. Finally,
microbes were categorized as “incomplete/uncertain” if we were unable to identify any thiamine
transporters and/or sufficient genes to carry out thiamine biosynthesis or recycling. Additionally, using
an approach identical to that described by Degnan et al. (6), a set of 13 core genes conserved among
all three domains of life were identified in the 641 gut microbial genomes and aligned, and a phylogeny
was reconstructed by the maximum likelihood method.
Accession number(s). RNA-seq data generated for this project have been submitted to the NCBI SRA
database under accession no. SRP116143.
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